Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

DFM:AMANAT
DFM:AMANATDiversified Financial

Middle Eastern Penny Stocks With At Least US$100M Market Cap

The Middle Eastern stock markets have recently experienced fluctuations, with many Gulf markets retreating due to geopolitical tensions in the region. In such a climate, investors often look for opportunities that balance potential growth with financial resilience. Penny stocks, while sometimes seen as relics of past market eras, continue to offer intriguing possibilities when backed by robust financials. This article will explore three penny stocks that stand out for their strength and...
TASE:CMDR
TASE:CMDRIT

3 Middle Eastern Dividend Stocks To Consider With Up To 5.1% Yield

In recent weeks, Gulf stock markets have experienced a downturn amid geopolitical tensions and stalled diplomatic efforts between the U.S. and Iran, leading to investor caution across the region. Despite these challenges, dividend stocks remain an attractive option for investors seeking income stability in uncertain times, as they can provide consistent returns even when market volatility is high.
ENXTPA:COFA
ENXTPA:COFAInsurance

A Look At COFACE (ENXTPA:COFA) Valuation After Recent Share Price Weakness

Recent share performance and business scale COFACE (ENXTPA:COFA) has drawn attention after recent share price pressure, with the stock down 5.7% over the past month and 0.9% over the past 3 months, compared with a year-to-date decline of 5.9%. At a last close of €14.72 and a market value of about €2.2b, the trade credit insurer operates globally across regions including Northern Europe, the Mediterranean and Africa, North America, Latin America and Asia-Pacific. The group reports annual...
NYSE:PHIN
NYSE:PHINAuto Components

A Look At PHINIA (PHIN) Valuation As Shares Trade Near Popular Fair Value Estimates

Recent price action and business snapshot PHINIA (PHIN) has drawn investor attention after a recent move that leaves the stock around $80.03, with performance figures available over the past week, month, past 3 months and year. See our latest analysis for PHINIA. Recent gains have been steady rather than sudden, with an upward trend in short term share price returns and a 1 year total shareholder return of 95.36% pointing to strong momentum around PHINIA at the current US$80.03 level. If...
NYSE:BW
NYSE:BWElectrical

Babcock & Wilcox (BW) Is Down 8.9% After ESOP Share Shelf And Contract Lawsuits Filed

Babcock & Wilcox Enterprises recently filed a US$95.2 million shelf registration for 5,000,000 common shares tied to an ESOP-related offering, while multiple law firms have since launched class action lawsuits alleging false and misleading statements about a major power generation contract and related conflicts of interest. The combination of a fresh equity shelf and lawsuits focused on revenue recognition and a key shareholder’s alleged conflicts raises questions about governance, contract...
NYSE:PAGS
NYSE:PAGSDiversified Financial

PagSeguro Digital (PAGS) Valuation Check After Fast-Growing Credit Portfolio And AI-Driven Efficiency Push

PagSeguro Digital (PAGS) is back in focus after its Q1 2026 earnings update highlighted 36% year over year credit portfolio growth and a renewed push to scale credit alongside its payments and digital banking operations. See our latest analysis for PagSeguro Digital. Despite the Q1 2026 update putting credit growth in the spotlight, recent momentum in the stock has been weaker, with the share price down 10.05% over the past month and 13.08% over the past quarter. The 1 year total shareholder...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Mixed Lupus Win And Parkinson’s Setback Might Change The Case For Investing In Biogen (BIIB)

In May 2026, Biogen’s partner UCB reported positive Phase 3 PHOENYCS GO results for dapirolizumab pegol in moderate-to-severe active systemic lupus erythematosus, while Biogen and Denali ended development of BIIB122 for idiopathic Parkinson’s disease after the Phase 2b LUMA trial failed to show clinical benefit versus placebo. Together, these updates highlight how Biogen’s pipeline remains a mix of setbacks in broader neurodegeneration and promise in high-need autoimmune indications such as...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

A Look At Bicara Therapeutics (BCAX) Valuation After New Ficerafusp Alfa Survival Data And Phase 3 Progress

Bicara Therapeutics (BCAX) shares are in focus after the company released three-year follow-up data for its lead candidate ficerafusp alfa in combination with pembrolizumab in recurrent or metastatic HPV-negative head and neck cancer. See our latest analysis for Bicara Therapeutics. At a latest share price of $20.00, Bicara’s short term performance has been mixed, with the 7 day share price return down 7.32% and the 30 day share price return down 11.97%. However, the year to date share price...
NYSE:EQT
NYSE:EQTOil and Gas

How Investors May Respond To EQT (EQT) Earnings Beat Amid Rising Data Center Gas Demand

EQT Corporation recently reported stronger-than-expected quarterly earnings, helped by higher natural gas prices and volumes as power-hungry data centers and liquefied natural gas exports lifted demand. Analysts and investors have highlighted EQT’s position as a large, low-cost U.S. natural gas producer with long-lived Marcellus shale assets that could benefit from this data center-driven energy usage. We’ll now examine how EQT’s earnings beat and rising data center-related gas demand could...
NYSE:UPS
NYSE:UPSLogistics

Is It Time To Reassess UPS (NYSE:UPS) After Its Recent Share Price Recovery

Wondering if United Parcel Service (UPS) stock at around US$108.67 still offers value, or if the easy gains are already behind it. The share price has moved 4.0% over the last week, 12.8% over the last month, 7.6% year to date, while the past 1 year return sits at 17.9% and the stock is still down 25.3% over 3 years and 32.3% over 5 years. Those mixed returns sit against a backdrop of ongoing focus on parcel volumes, cost efficiency and broader logistics demand, with investors weighing how...
NYSE:DQ
NYSE:DQSemiconductor

Assessing Daqo New Energy (DQ) Valuation After New AI Data Center Energy Storage Expansion

Daqo New Energy (DQ) has drawn fresh attention after its subsidiary agreed to build a new manufacturing base in Kunshan for next generation energy solutions tailored to artificial intelligence data centers. See our latest analysis for Daqo New Energy. The expansion news comes after a weak run in the stock, with the share price down 19.5% over the past 30 days and 45.85% year to date. However, the 1 year total shareholder return of 17.66% points to a more mixed picture over a longer...
NasdaqGS:PPLI
NasdaqGS:PPLIInteractive Media and Services

A Look At IAC (IAC) Valuation As Shares Track Choppy Recent Returns

IAC (IAC) recently drew investor attention as its stock closed at US$42.24, with a market value of about US$3.2b. This followed another choppy week for returns across its media and internet portfolio. See our latest analysis for IAC. The recent pullback, with a 1-day share price return of 1.45% down and a 7-day share price return of 4.46% down, comes after a 90-day share price return of 9.02% and a 1-year total shareholder return of 15.47%. This suggests that longer term momentum is still...
NYSE:SWX
NYSE:SWXGas Utilities

Southwest Gas’s US$6.3 Billion 2026–2030 Network Plan Might Change The Case For Investing In SWX

Southwest Gas Holdings has outlined a US$6.30 billion capital program for 2026–2030 to support its regulated gas distribution and transmission networks across Arizona, Nevada, and California. This long-term infrastructure plan coincides with a recent 2.15% uplift in the 2026 earnings-per-share consensus estimate, highlighting rising confidence in the company’s future profitability profile. We’ll now explore how Southwest Gas’s US$6.30 billion infrastructure plan could reshape its existing...
ASX:TNE
ASX:TNESoftware

Does Technology One (ASX:TNE) Attracting Norges Bank Deepen The Case For Its Recurring Revenue Model?

Norges Bank recently increased its stake in Technology One, a provider of enterprise software to governments, councils, universities, and large organisations, reinforcing institutional interest in the company’s business model and long-term focus. This move highlights how confidence from a major global investor can matter for a software firm that already leans heavily on recurring revenue and long-term contracts. We’ll now examine how this increased institutional backing may influence...